Ann: MDR - ASX Small and Mid-Cap Conference March 2024, page-2

Would have been good to get an update on how they are tracking in 2H24

They had ~14m loss in 2H23 driven by ~36m in expenses (which is roughly also their expenses in 1H24) so at a 60% margin, they need ~60m in revenues (or ~50m revenues if 2H24 still losses money, but they stay profitable over FY24).

It appears that Project Stop is adding a decent uplift to revenues....5-7% of FY24 revenues (that is 6-8m in revenues if we assume they do ~125m in total.....so a significant portion of MDR's revenues

More information here
https://projectstop.mymedadvisor.com/

It appears that this was initially funded by the federal govt, but not sure how this is now being paid for and it does not indicate if this is compulsory, but seems like a reasonable resource (esp if MDR is used by most Australian pharmacies)